Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Neuroone Medical Technologies (NMTC) over the last 10 years, with Q4 2025 value amounting to 0.9.
- Neuroone Medical Technologies' Asset Utilization Ratio fell 711.18% to 0.9 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.9, marking a year-over-year decrease of 711.18%. This contributed to the annual value of 1.13 for FY2025, which is 11962.95% up from last year.
- Neuroone Medical Technologies' Asset Utilization Ratio amounted to 0.9 in Q4 2025, which was down 711.18% from 0.84 recorded in Q3 2025.
- Neuroone Medical Technologies' 5-year Asset Utilization Ratio high stood at 1.05 for Q1 2025, and its period low was 0.01 during Q1 2021.
- In the last 5 years, Neuroone Medical Technologies' Asset Utilization Ratio had a median value of 0.24 in 2023 and averaged 0.39.
- Per our database at Business Quant, Neuroone Medical Technologies' Asset Utilization Ratio tumbled by 3602.29% in 2021 and then surged by 190818.68% in 2023.
- Over the past 5 years, Neuroone Medical Technologies' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then soared by 100.53% to 0.02 in 2022, then surged by 1704.59% to 0.4 in 2023, then surged by 139.58% to 0.97 in 2024, then decreased by 7.11% to 0.9 in 2025.
- Its Asset Utilization Ratio stands at 0.9 for Q4 2025, versus 0.84 for Q3 2025 and 0.87 for Q2 2025.